Solana Beach, CA, United States of America

Kenneth Barrett

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Bp Corporation North America Inc.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth Barrett. Retrieved from https://idiyas.com/inventor/kenneth-barrett-6zgiqx3c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenneth Barrett: Innovator in Glucanase Technology

Introduction

Kenneth Barrett is a notable inventor based in Solana Beach, California. He has made significant contributions to the field of biotechnology, particularly in the development of glucanases. His work focuses on the enzymatic processes that have applications in various industries, including agriculture and biofuels.

Latest Patents

Kenneth Barrett holds a patent for "Glucanases, nucleic acids encoding them and methods for making and using them." This invention relates to polypeptides that exhibit glucanase activity, such as endoglucanase, mannanase, and xylanase. The patent details methods for hydrolyzing 1,4-beta-D-glycosidic linkages in cellulose and other plant materials. Additionally, it discusses the design of new enzymes with enhanced activity and stability under varying pH and temperature conditions.

Career Highlights

Kenneth Barrett is associated with Bp Corporation North America Inc., where he applies his expertise in enzyme technology. His innovative work has the potential to revolutionize processes that rely on glucanase activity, contributing to advancements in sustainable practices.

Collaborations

Throughout his career, Kenneth has collaborated with notable colleagues, including Brian Steer and Shaun Healey. These partnerships have fostered a collaborative environment that enhances research and development in enzyme technology.

Conclusion

Kenneth Barrett's contributions to glucanase technology exemplify the impact of innovation in biotechnology. His patent and ongoing work continue to influence various applications, showcasing the importance of enzymatic research in modern science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…